Cargando…

Longitudinal Changes in Cholesterol Efflux Capacities in Patients With Coronary Artery Disease Undergoing Lifestyle Modification Therapy

BACKGROUND: Our objective was to identify the determinants of high‐density lipoprotein cholesterol efflux capacity (HDL‐CEC) changes in patients with coronary artery disease who participated in a lifestyle modification program aimed at increasing physical activity levels and improving diet quality....

Descripción completa

Detalles Bibliográficos
Autores principales: Boyer, Marjorie, Lévesque, Valérie, Poirier, Paul, Marette, André, Mitchell, Patricia L., Mora, Samia, Mathieu, Patrick, Després, Jean‐Pierre, Larose, Éric, Arsenault, Benoit J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6015361/
https://www.ncbi.nlm.nih.gov/pubmed/29858367
http://dx.doi.org/10.1161/JAHA.118.008681
_version_ 1783334395061469184
author Boyer, Marjorie
Lévesque, Valérie
Poirier, Paul
Marette, André
Mitchell, Patricia L.
Mora, Samia
Mathieu, Patrick
Després, Jean‐Pierre
Larose, Éric
Arsenault, Benoit J.
author_facet Boyer, Marjorie
Lévesque, Valérie
Poirier, Paul
Marette, André
Mitchell, Patricia L.
Mora, Samia
Mathieu, Patrick
Després, Jean‐Pierre
Larose, Éric
Arsenault, Benoit J.
author_sort Boyer, Marjorie
collection PubMed
description BACKGROUND: Our objective was to identify the determinants of high‐density lipoprotein cholesterol efflux capacity (HDL‐CEC) changes in patients with coronary artery disease who participated in a lifestyle modification program aimed at increasing physical activity levels and improving diet quality. METHODS AND RESULTS: A total of 86 men with coronary artery disease aged between 35 and 80 years participated in a 1‐year lifestyle modification program that aimed to achieve a minimum of 150 minutes of aerobic physical activity weekly and improve diet quality. HDL‐CECs were measured before and after the 1‐year intervention using (3)H‐cholesterol–labeled J774 and HepG2 cells. Visceral, subcutaneous, and cardiac adipose tissue levels were assessed before and after the intervention using magnetic resonance imaging. Lipoprotein particle size and concentrations were measured by proton nuclear magnetic resonance spectroscopy and a complete lipoprotein‐lipid profile was obtained. At baseline, the best correlate of HDL‐CECs were apolipoprotein AI (R (2)=0.35, P<0.0001) and high‐density lipoprotein cholesterol (R (2)=0.21, P<0.0001) for J774‐HDL‐CECs and HepG2‐HDL‐CECs, respectively. Baseline and longitudinal changes in HDL‐CECs were associated with several lipoprotein size and concentration indices, although high‐density lipoprotein cholesterol was the best predictor of longitudinal changes in J774‐HDL‐CECs (R (2)=0.18, P=0.002) and apolipoprotein AI was found to be the best predictor of longitudinal changes in HepG2 cholesterol efflux capacities (R (2)=0.21, P=0.002). CONCLUSIONS: Results of this study suggest that increases in high‐density lipoprotein cholesterol and apolipoprotein AI levels typically observed in patients with coronary artery disease undergoing healthy lifestyle modification therapy may be indicative of higher plasma concentrations of functional high‐density lipoprotein particles.
format Online
Article
Text
id pubmed-6015361
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-60153612018-07-05 Longitudinal Changes in Cholesterol Efflux Capacities in Patients With Coronary Artery Disease Undergoing Lifestyle Modification Therapy Boyer, Marjorie Lévesque, Valérie Poirier, Paul Marette, André Mitchell, Patricia L. Mora, Samia Mathieu, Patrick Després, Jean‐Pierre Larose, Éric Arsenault, Benoit J. J Am Heart Assoc Original Research BACKGROUND: Our objective was to identify the determinants of high‐density lipoprotein cholesterol efflux capacity (HDL‐CEC) changes in patients with coronary artery disease who participated in a lifestyle modification program aimed at increasing physical activity levels and improving diet quality. METHODS AND RESULTS: A total of 86 men with coronary artery disease aged between 35 and 80 years participated in a 1‐year lifestyle modification program that aimed to achieve a minimum of 150 minutes of aerobic physical activity weekly and improve diet quality. HDL‐CECs were measured before and after the 1‐year intervention using (3)H‐cholesterol–labeled J774 and HepG2 cells. Visceral, subcutaneous, and cardiac adipose tissue levels were assessed before and after the intervention using magnetic resonance imaging. Lipoprotein particle size and concentrations were measured by proton nuclear magnetic resonance spectroscopy and a complete lipoprotein‐lipid profile was obtained. At baseline, the best correlate of HDL‐CECs were apolipoprotein AI (R (2)=0.35, P<0.0001) and high‐density lipoprotein cholesterol (R (2)=0.21, P<0.0001) for J774‐HDL‐CECs and HepG2‐HDL‐CECs, respectively. Baseline and longitudinal changes in HDL‐CECs were associated with several lipoprotein size and concentration indices, although high‐density lipoprotein cholesterol was the best predictor of longitudinal changes in J774‐HDL‐CECs (R (2)=0.18, P=0.002) and apolipoprotein AI was found to be the best predictor of longitudinal changes in HepG2 cholesterol efflux capacities (R (2)=0.21, P=0.002). CONCLUSIONS: Results of this study suggest that increases in high‐density lipoprotein cholesterol and apolipoprotein AI levels typically observed in patients with coronary artery disease undergoing healthy lifestyle modification therapy may be indicative of higher plasma concentrations of functional high‐density lipoprotein particles. John Wiley and Sons Inc. 2018-06-01 /pmc/articles/PMC6015361/ /pubmed/29858367 http://dx.doi.org/10.1161/JAHA.118.008681 Text en © 2018 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Research
Boyer, Marjorie
Lévesque, Valérie
Poirier, Paul
Marette, André
Mitchell, Patricia L.
Mora, Samia
Mathieu, Patrick
Després, Jean‐Pierre
Larose, Éric
Arsenault, Benoit J.
Longitudinal Changes in Cholesterol Efflux Capacities in Patients With Coronary Artery Disease Undergoing Lifestyle Modification Therapy
title Longitudinal Changes in Cholesterol Efflux Capacities in Patients With Coronary Artery Disease Undergoing Lifestyle Modification Therapy
title_full Longitudinal Changes in Cholesterol Efflux Capacities in Patients With Coronary Artery Disease Undergoing Lifestyle Modification Therapy
title_fullStr Longitudinal Changes in Cholesterol Efflux Capacities in Patients With Coronary Artery Disease Undergoing Lifestyle Modification Therapy
title_full_unstemmed Longitudinal Changes in Cholesterol Efflux Capacities in Patients With Coronary Artery Disease Undergoing Lifestyle Modification Therapy
title_short Longitudinal Changes in Cholesterol Efflux Capacities in Patients With Coronary Artery Disease Undergoing Lifestyle Modification Therapy
title_sort longitudinal changes in cholesterol efflux capacities in patients with coronary artery disease undergoing lifestyle modification therapy
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6015361/
https://www.ncbi.nlm.nih.gov/pubmed/29858367
http://dx.doi.org/10.1161/JAHA.118.008681
work_keys_str_mv AT boyermarjorie longitudinalchangesincholesteroleffluxcapacitiesinpatientswithcoronaryarterydiseaseundergoinglifestylemodificationtherapy
AT levesquevalerie longitudinalchangesincholesteroleffluxcapacitiesinpatientswithcoronaryarterydiseaseundergoinglifestylemodificationtherapy
AT poirierpaul longitudinalchangesincholesteroleffluxcapacitiesinpatientswithcoronaryarterydiseaseundergoinglifestylemodificationtherapy
AT maretteandre longitudinalchangesincholesteroleffluxcapacitiesinpatientswithcoronaryarterydiseaseundergoinglifestylemodificationtherapy
AT mitchellpatricial longitudinalchangesincholesteroleffluxcapacitiesinpatientswithcoronaryarterydiseaseundergoinglifestylemodificationtherapy
AT morasamia longitudinalchangesincholesteroleffluxcapacitiesinpatientswithcoronaryarterydiseaseundergoinglifestylemodificationtherapy
AT mathieupatrick longitudinalchangesincholesteroleffluxcapacitiesinpatientswithcoronaryarterydiseaseundergoinglifestylemodificationtherapy
AT despresjeanpierre longitudinalchangesincholesteroleffluxcapacitiesinpatientswithcoronaryarterydiseaseundergoinglifestylemodificationtherapy
AT laroseeric longitudinalchangesincholesteroleffluxcapacitiesinpatientswithcoronaryarterydiseaseundergoinglifestylemodificationtherapy
AT arsenaultbenoitj longitudinalchangesincholesteroleffluxcapacitiesinpatientswithcoronaryarterydiseaseundergoinglifestylemodificationtherapy